Aurobindo Pharma Ltd KYS Report: Ownership & Insights

15:59 Dec 12

Aurobindo Pharma Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

1195.10

+22.90 (+1.95%)

NSE BSE

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Aurobindo Pharma Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals 15:59 Dec 12

1195.10

+22.90 (+1.95%)

54/100 Medium Financial Strength

Quality

43/100 Mid Valuation

Valuation

55/100 Technically Neutral

Technical

SWOT

Strength

Weakness

Opportunity

Threat

69.41K

Market Cap (Cr)

20.28

PE Ratio

1.98

Price to Book Ratio

52.36

RSI

10.98 %

Net Profit Margin

Rating Based on 9 Analysts

Buy 89%

Hold 11%

Sell 0%

Buy

The consensus recommendation from 8 analysts for Aurobindo Pharma Ltd. is Buy

Analyst Price Target

The average price target is 1349.22 with a high estimate of 1591 and low estimate of 1185

High Average Low

Current 1195.10

1591.00

1349.22

1185.00

Disclaimer:The analysis information is for reference only and does not constitude an investment recommendation

SWOT

Strength Weakness Opportunity Threats

Download Our App On:

Back

Back

Back

Back

OTP sent to your mobile number. Please enter it below to verify.

59 s

Verify Email OTP

OTP sent to

Didn’t receive a code? Don’t worry Retry in 59 s

Dear User,
please complete your profile!

Email ID Already Exists

Location Saved Successfully

Email Id Verified Successfully

Complete 2 steps process within few minutes

Step 2

OR

Enter OTP Sent on Your

59 s

Back

59 s

Multiple User Exist With this Email/Mobile numbe, try login through Client id and password

Multiple User Exist With this Email/Mobile numbe, try login through Client id and password